- Report
- April 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- April 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- April 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- March 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- February 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- February 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- February 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- March 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,396GBP
- Report
- February 2026
- 386 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 569 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 274 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 341 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 271 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 212 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 387 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 389 Pages
Global
From €5102EUR$5,850USD£4,425GBP
- Report
- February 2026
- 228 Pages
Global
From €5102EUR$5,850USD£4,425GBP

The Transcriptomics market is a segment of the biotechnology industry that focuses on the study of gene expression. It involves the analysis of the transcriptome, which is the set of all RNA molecules in a cell. This includes mRNA, tRNA, and rRNA. Transcriptomics is used to study gene expression, regulation, and function. It is used to identify and characterize genes, as well as to understand the role of genes in disease and development. Transcriptomics can also be used to identify biomarkers for diagnosis and prognosis, and to develop new therapeutic targets.
Some companies in the Transcriptomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more